Cytokine Logo banner banner banner banner
banner banner banner banner banner
Home About Us Products Partners Contact Us
News
Management
In the News
 

February 25, 2008

Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment

 

October 29, 2007

Cytokine Announces Oral Efficacy of Anti-Cytokine Semapimod

 

August 2, 2007

Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors

 

May 3, 2007

Cytokine PharmaSciences, Inc. Issued Patent for MIF Gene Polymorphism Diagnostics

 

March 29, 2007

CAMERON MACDONALD APPOINTED MANAGING DIRECTOR OF CONTROLLED THERAPEUTICS (SCOTLAND) LIMITED

 

January 9, 2007

Presidio Pharmaceuticals Licenses Nuclear Exclusion Compounds from Cytokine PharmaSciences

 

November 29, 2006

Beijing Med-Pharm Corporation and Cytokine PharmaSciences, Inc. Reach Agreement on Development and Commercialization of Second-Generation Obstetrics Product in China

 

November 20, 2006

Genmab Licenses MIF Receptor Target from Cytokine PharmaSciences

 

May 9, 2003

Cytokine PharmaSciences Licenses Anti-MIF Technology To Baxter Healthcare Corporation

 

April 3, 2003

Cytokine PharmaSciences Licenses Obstetric Product

Cytokine Logo

Cytokine PharmaSciences Inc. • Walnut Hill Plaza • 150 South Warner Road • Suite 420 • King of Prussia, PA 19406 • Telephone 610-687-1776

MANAGEMENT | IN THE NEWS

HOME | ABOUT US | PRODUCTS | PARTNERS | RESOURCES | CONTROLLED THERAPEUTICS (SCOTLAND) | CONTACT US

banner